Masayuki Yamamoto
Affiliations: | Graduate School of Science | The University of Tokyo |
Google:
"Masayuki Yamamoto"
BETA: Related publications
See more...
Publications
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
Baird L, Suzuki T, Takahashi Y, et al. (2020) Geldanamycin-derived HSP90 Inhibitors are Synthetic Lethal with NRF2. Molecular and Cellular Biology |
Shimizu S, Mimura J, Hasegawa T, et al. (2020) Association of single nucleotide polymorphisms in the NRF2 promoter with vascular stiffness with aging. Plos One. 15: e0236834 |
Hayashi M, Kuga A, Suzuki M, et al. (2020) Microenvironmental activation of Nrf2 restricts the progression of Nrf2-activated malignant tumors. Cancer Research |
Ashino T, Yamamoto M, Numazawa S. (2020) Nrf2 Antioxidative System is Involved in Cytochrome P450 Gene Expression and Activity: A Delay in Pentobarbital Metabolism in Nrf2-deficient Mice. Drug Metabolism and Disposition: the Biological Fate of Chemicals |
Yamaoka A, Suzuki M, Katayama S, et al. (2020) EVI1 and GATA2 misexpression induced by inv(3)(q21q26) contribute to megakaryocyte-lineage skewing and leukemogenesis. Blood Advances. 4: 1722-1736 |
Yamazaki H, Kasai S, Mimura J, et al. (2020) Ribosome binding protein GCN1 regulates the cell cycle and cell proliferation and is essential for the embryonic development of mice. Plos Genetics. 16: e1008693 |
Baird L, Yamamoto M. (2020) The Molecular Mechanisms Regulating the KEAP1-NRF2 Pathway. Molecular and Cellular Biology |
Aoki Y, Taniguchi Y, Matsumoto M, et al. (2020) Oxidative-stress-driven mutagenesis in the small intestine of the gpt delta mouse induced by oral administration of potassium bromate. Mutation Research. 850: 503136 |
Shichino Y, Otsubo Y, Yamamoto M, et al. (2020) Meiotic gene silencing complex MTREC/NURS recruits the nuclear exosome to YTH-RNA-binding protein Mmi1. Plos Genetics. 16: e1008598 |
Nabeshima T, Hamada S, Taguchi K, et al. (2020) Keap1 deletion accelerates mutant K-ras/p53-driven cholangiocarcinoma. American Journal of Physiology. Gastrointestinal and Liver Physiology |